SCHEMBL7311382

SCHEMBL7311382

O=C(c1ccccc1C(F)(F)F)N1c2ccccc2OCC1CCN1CCc2c([nH]c3ccccc23)C1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.47
SIGMAR1 Q99720 1/20 0.41
GRIN2B Q13224 1/20 0.41
HTR1A P08908 2/20 0.41
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
CDK4 P11802 2/20 0.39
CCND1 P24385 2/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311376 0.86 LMNA (0.54) TRPV1SIGMAR1GRIN2BHTR1AADRA1D
SCHEMBL7304705 0.72 SCD (0.34) HTR1A
SCHEMBL7300850 0.66 MAPT (0.44)
SCHEMBL28117214 0.64 HDAC1 (0.58) SIGMAR1GRIN2BHTR1AHDAC1HDAC6
SCHEMBL967638 0.63 HDAC1 (0.60) TRPV1SIGMAR1GRIN2BHTR1AHDAC1
SCHEMBL7249585 0.63 SIGMAR1 (0.74) SIGMAR1GRIN2BHTR1A
SCHEMBL28929350 0.63 SIGMAR1 (0.60) TRPV1SIGMAR1GRIN2BHTR1AHDAC1
Trifluoroacetic Acid SCHEMBL7658811 0.63 HTR1A (0.53) SIGMAR1GRIN2BHTR1AHDAC1HDAC6
SCHEMBL1415530 0.63 HTR1A (0.81) SIGMAR1GRIN2BHTR1A
SCHEMBL22213679 0.63 SIGMAR1 (0.56) SIGMAR1GRIN2BHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0666260-B1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1999-08-04 EP disclosed
EP-0666260-A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy SYNTHELABO (FR) 1995-08-09 EP disclosed